Customers of genetic data outfit 23andMe may be at greater risk than they realize, suggests a New York Times story that ...
A plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data ...
“While we will delete the majority of your personal information, we are required to retain some information to comply with ...
周五(10月4日),成分股uniQure NV收涨23.90%,Voyager Therapeutics涨17.53%,Travere Therapeutics涨11.58%,bluebird bio涨9.65%,Alector涨9.48%,ATAI Life Sciences BV涨9.43%,Adaptive Biotechnologies涨9.09%,Enliven Therapeutics ...
Me's financial troubles may lead to customers' genetic data exchanging hands if an acquisition occurs. Here's how to delete ...
在动荡的市场环境中,ME股票暴跌至52周低点,价格仅为0.29美元。这一显著下跌反映了该公司的整体趋势,过去一年其价值已下降了惊人的57.86%。投资者一直密切关注ME的表现,因为股票当前的位置与过去更为强劲的数据形成鲜明对比。52周低点作为公司近期困境的关键指标,可能会促使投资者重新评估有关ME未来前景的投资策略。 在其他近期新闻中,23andMe正在应对几项重大发展。由于与GSK合作关系的终止 ...
On Thursday, 23andMe Holding Co. (ME) stock saw a modest uptick, ending the day at $0.39 which represents no change from the prior close of $0.39. The stock opened at $0.39 and touched a low of $0.37 ...
After 23andMe’s board of directors resigns, the president of encrypted messaging app Signal joins other security experts in ...
Genetic surveillance company 23andMe, once a $6bn prospect, is now a penny stock on the verge of doom. So "what happens to ...
DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no ...
The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...